ibc-vs01
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT00057499)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- InsulinImmunity, desensitized
INS immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ibc-vs01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00057499 | Phase 1 | Mar 1, 2003 | Immune Tolerance Network, Joslin Diabetes Center, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Tolerance Network | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Joslin Diabetes Center | Academic/Hospital | 1 | 0 | 1 | 2003 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2003 |
3 organizations
Page 1 / 1